Compounds useful as modulators of TRPM8
The present invention includes compounds useful as modulators of TRPM8, such as compounds of Formula (I) and the subgenus and species thereof; personal products containing those compounds; and the use of those compounds and the personal products, particularly the use of increasing or inducing chemesthetic sensations, such as cooling or cold sensations.
1. A compound having a structural Formula (II):
or a salt or solvate thereof,
wherein
Ar is optionally substituted aryl, optionally substituted carbocyclyl, or optionally substituted heteroaryl;
Y is oxygen or sulfur;
Z is nitrogen or CR;
R is hydrogen or lower alkyl;
X 1 —X 2 is O—CR 2a R 2b , or CR 5 ═CR 6 ;
R 2a , R 2b , R 5 , and R 6 are independently hydrogen or lower alkyl;
R 1 is an optionally substituted group selected from the group consisting of pyrrolyl, furanyl, thienyl, and pyrazolyl;
n is 0, 1, 2, or 3; and
each R 2 is independently optionally substituted alkyl, optionally substituted heteroalkyl, optionally substituted alkenyl, alkoxy, hydroxyl, amino, N-alkyl amino, N-dialkyl amino, halo, nitro, cyano, acyl, carboxyl, carboxyl ester, or amide,
wherein each optional substituent is selected from the group consisting of alkyl, heteroalkyl, alkenyl, alkoxy, hydroxyl, amino, N-alkyl amino, N-dialkyl amino, halo, nitro, cyano, acyl, carboxyl, carboxyl ester, or amide; or two substituents, together with the atoms to which they are attached, form a carbocyclyl optionally substituted with alkyl or alkoxy; or two substituents, together with the atoms to which they are attached, form a heterocyclyl containing one or more heteroatom(s) selected from nitrogen, oxygen, and sulfur.
2. The compound of claim 1 , wherein Ar is an optionally substituted phenyl.
3. The compound of claim 1 , wherein Ar is optionally substituted heteroaryl, wherein the heteroaryl is a five- or six-membered heteroaryl containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur.
4. The compound of claim 3 , wherein Ar is an optionally substituted group selected from the group consisting of pyrrolyl, furanyl, thienyl, pyrazolyl, triazolyl, oxazolyl, thiazolyl, isoxazolyl, isothiazolyl, pyridyl, pyrimidyl, and triazinyl.
5. The compound of claim 1 , wherein each optional substituent is selected from the group consisting of alkyl, alkoxy, hydroxyl, halo, nitro, and cyano; or two substituents, together with the atoms to which they are attached, form a carbocyclyl; or two substituents, together with the atoms to which they are attached, form a heterocyclyl containing one or more heteroatom(s) selected from nitrogen, oxygen, and sulfur.
6. The compound of claim 1 , wherein R 2b , R 5 and R 6 are hydrogen.
7. The compound of claim 1 , wherein R 1 is an optionally substituted group selected from the group consisting of pyrrolyl, furanyl, and pyrazolyl.
8. The compound of claim 1 , wherein X 1 —X 2 is O—CH 2 , O—CH(CH 3 ), or O—CH(CH 2 CH 3 ).
9. The compound of claim 1 , wherein X 1 —X 2 is CH═CH.
10. A compound having a structural Formula (III):
or a salt or solvate thereof,
wherein
Ar is optionally substituted aryl, optionally substituted carbocyclyl, or optionally substituted heteroaryl;
X 1 —X 2 is O—CR 2a R 2b , CHR 3 —CHR 4 , CR 5 ═CR 6 , or cycloalkyl;
R 2a , R 2b , R 3 , R 4 , R 5 , and R 6 are independently hydrogen or lower alkyl;
Z 1 and Z 2 are independently nitrogen or CH, provided that Z 1 and Z 2 are not both nitrogen; and
R 1 is an optionally substituted five-membered heteroaryl,
wherein each optional substituent is selected from the group consisting of alkyl, heteroalkyl, alkenyl, alkoxy, hydroxyl, amino, N-alkyl amino, N-dialkyl amino, halo, nitro, cyano, acyl, carboxyl, carboxyl ester, or amide; or two substituents, together with the atoms to which they are attached, form a carbocyclyl optionally substituted with alkyl or alkoxy; or two substituents, together with the atoms to which they are attached, form a heterocyclyl containing one or more heteroatom(s) selected from nitrogen, oxygen, and sulfur.
11. The compound of claim 10 , wherein
Ar is optionally substituted aryl; and
X 1 —X 2 is O—CR 2a R 2b , CH 2 —CH 2 , or CH═CH.
12. The compound of claim 11 , wherein Ar is optionally substituted phenyl.
13. The compound of claim 10 , wherein
Ar is optionally substituted heteroaryl; and
X 1 —X 2 is O—CR 2a R 2b , CH 2 —CH 2 , or CH═CH.
14. The compound claim 10 , wherein Z 1 and Z 2 are CH.
15. The compound of claim 10 , wherein R 2a and R 2b are hydrogen.
16. The compound of claim 10 having a structure of:
or a salt or solvate thereof.
17. The compound of claim 10 having a structure of:
or a salt or solvate thereof.
18. The compound of claim 10 having a structure of:
or a salt or solvate thereof.
19. A compound selected from the group consisting of:
or a salt or solvate thereof.
20. A personal product comprising a compound of claim 1 , or a salt or solvate thereof.
21. The personal product of claim 20 , which is a composition further comprising at least one carrier.
22. The personal product of claim 21 , wherein the composition is an ingestible composition or personal care composition.
23. The personal product of claim 22 , wherein the ingestible composition is a food or beverage.
24. The personal product of claim 21 , wherein the composition is in form of a solid, semi-solid, plaster, solution, suspension, lotion, cream, foam, gel, paste, emulsion, or a combination thereof.
25. The personal product of claim 21 , wherein the compound in the composition is in a concentration ranging from about 0.0001 ppm to 100,000 ppm.
26. The personal product of claim 25 , wherein the compound in the composition is in a concentration ranging from about 1 ppm to 500 ppm.
27. The personal product of claim 20 , which is a textile product or a packaging material.
28. The personal product of claim 20 , which is for human or animal consumption or use.
29. A method of modulating transient receptor potential channel melastatin member 8 (TRPM8) comprising contacting the receptor with a compound of claim 1 , or a salt or solvate thereof.
30. The method of claim 29 , which is in vitro or in vivo.
31. The method of claim 29 , wherein the compound is a TRPM8 receptor agonist.
32. A method of modulating the cooling sensation of a composition comprising combining the composition with a compound of claim 1 , or a salt or solvate thereof, to form a modified composition.
33. A method of inducing a cooling sensation in a human or animal comprising contacting the human or animal with a compound of claim 1 , or a salt or solvate thereof.
34. A personal product comprising a compound of claim 16 , or a salt or solvate thereof.
35. The personal product of claim 34 , further comprising at least one carrier.
36. The personal product of claim 35 , which is an ingestible composition or personal care composition.
37. The personal product of claim 36 , wherein the ingestible composition is a food or beverage.
38. The personal product of claim 34 , which is a textile product or a packaging material.